New genome sequencing algorithm boosts human genome completeness by 20%, improving variant detection and advancing personalized medicine.

To prevent algorithmic bias, the authors call for multivariable modeling frameworks that jointly incorporate biological sex, genetic ancestry, and gender-related life-course exposures.

TruPath™ Genome offers more complete genome, with the simplest sample to sequencer workflow, and the new AGBT data ...

TruPath™ Genome offers more complete genome, with the simplest sample to sequencer workflowData presented at AGBT ...

Rare disease is a major – and growing – area of clinical research and drug development. Of the FDA’s 46 novel drug approvals ...

Illumina introduces TruPath Genome, setting a new standard in genomic insight: San Diego Thursday, February 26, 2026, 16:00 Hrs [IST] Illumina, Inc. announced the launch of TruPat ...

Background Monogenic disorders are a major cause of fetal structural anomalies. Most genetic diagnoses involve de novo, biallelic or X linked variants; however, inherited variants in autosomal ...

Spread the loveIn the rapidly evolving landscape of health care, the concept of digital twins is emerging as a transformative technology that promises to enhance patient treatment and outcomes.

The Gene Synthesis Market has emerged as one of the most transformative segments within modern biotechnology, driven by rapid ...

Overview: The global Artificial Intelligence (AI) in drug discovery market is projected to grow at a rate of 25-30% over the ...

Anemia in young adult women is rarely caused by a single factor. Instead, it reflects a layered interaction of nutritional deficiencies, physiological demands, chronic illnesses, genetic ...